Skip to main content

Market Overview

Fate Therapeutics (NASDAQ: FATE)

76.70 +5.19 (7.26%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.68
7.558M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.44
2.515M
-0.43
5.9M
-0.48
11.142M
-11.63%
88.85%
Q4 2020
After-Hours
EPS:
REV:
-0.37
2.802M
-0.39
4.87M
-0.61
15.896M
-56.41%
226.41%
Q3 2020
After-Hours
EPS:
REV:
-0.40
2.429M
-0.36
6.97M
-0.68
7.558M
-88.89%
8.44%
Q2 2020
After-Hours
EPS:
REV:
-0.36
2.817M
-0.27
13.23M
-0.35
5.465M
-29.63%
-58.69%
Q1 2020
After-Hours
EPS:
REV:
-0.30
2.632M
-0.39
1.8M
-0.44
2.515M
-12.82%
39.72%
Q4 2019
After-Hours
EPS:
REV:
-0.25
1.661M
-0.39
1.8M
-0.37
2.802M
5.13%
55.67%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!